MoneyWorks4Me

The total revenue for the quarter ended March 2026 remained nearly unchanged at Rs. 3383.72 millions.Profit after Tax for the quarter ended March 2026 saw a decline of -44.92% from Rs. 275.89 millions to Rs. 151.97  millions.The company reported a degrowth in operating Profit to 395.16 millions from 497.74 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 3383.72 3287.53 2.93 13487.36 13117.84 2.82 13487.36 13117.84 2.82
Other Income 277.29 320.50 -13.48 1129.65 1241.92 -9.04 1129.65 1241.92 -9.04
PBIDT 395.16 497.74 -20.61 2104.25 2626.91 -19.90 2104.25 2626.91 -19.90
Interest 25.93 26.26 -1.26 100.38 153.09 -34.43 100.38 153.09 -34.43
PBDT 342.12 471.48 -27.44 1938.68 2473.82 -21.63 1938.68 2473.82 -21.63
Depreciation 124.21 100.93 23.07 455.03 395.45 15.07 455.03 395.45 15.07
PBT 217.91 370.55 -41.19 1483.65 2078.37 -28.61 1483.65 2078.37 -28.61
TAX 65.94 94.66 -30.34 367.25 468.39 -21.59 367.25 468.39 -21.59
Deferred Tax 33.28 12.05 176.18 -3.69 -7.14 -48.32 -3.69 -7.14 -48.32
PAT 151.97 275.89 -44.92 1116.40 1609.98 -30.66 1116.40 1609.98 -30.66
Equity 306.21 306.21 0.00 306.21 306.21 0.00 306.21 306.21 0.00
PBIDTM(%) 11.68 15.14 -22.87 15.60 20.03 -22.09 15.60 20.03 -22.09
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..